The specialty chemicals company's stock takes a breather this Thursday, May 7, at €62.85 midday, after a nearly 3% rise the previous day. This movement occurs in a nearly stable CAC 40, down 0.11%. Two analyst reports released this Thursday offer opposing conclusions.
Two analyst adjustments frame ARKEMA's session this May 7. Deutsche Bank slightly raises its price target to €52 from €50, while maintaining a 'hold' rating. The gap with the current price of €62.85 implies a potential downside of about 17%. On the other hand, Alphavalue adjusts its target from €73.30 to €73.50 and reaffirms its 'accumulate' rating, indicating a potential upside of about 17% at today's price. This divergence extends a debate that has been ongoing about the stock. The German office has been cautious for several months about the group's ability to restore its margins, in a context of weakened Advanced Materials. The publication of the Q1 2026 results confirmed an EBITDA decline of 14% to 283 million euros, affected by an unfavorable currency effect of about 20 million euros. However, the group has maintained its target of slight EBITDA growth at constant exchange rates for the year. The analyst consensus remains divided on the 2026 trajectory.
RSI at 66 Indicates the Rebound is Losing Steam
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
In terms of indicators, today's decline is in a tense zone. The stock is trading at its resistance level of €64.20, already tested at the session's high the previous day. The RSI at 66 is approaching the overbought threshold (70) after several sessions of gains, which corresponds to the pause observed at €62.85. The Bollinger Bands place the price in the upper half, close to the upper boundary at €63.69. Beyond today's movement, Arkema maintains an 8.36% gain over three months and remains well above its 200-day moving average at €56.05. The stock is among the notable declines in the SBF 120 this Thursday, in an index that is down 0.15% during the session. The next appointment on the financial calendar is the publication of the semi-annual results, scheduled for July 30, 2026.
Après des mois de janvier et février relativement faibles, la performance du premier trimestre a finalement été légèrement supérieure aux attentes.
Les volumes du Groupe sont stables, et la demande dans les segments clés est en hausse.
Risks mentioned
Impact potentiel de la crise au Moyen-Orient sur la demande mondiale.
Inflation des coûts des intrants résultant de la crise au Moyen-Orient.
Opportunities identified
Développement dans des marchés clés attractifs tels que les batteries et l'impression 3D.
Poursuite des efforts pour gérer strictement les coûts fixes.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
